Preoperative Tamsulosin to Prevent Postoperative Urinary Retention: A Randomized Controlled Trial

Preoperative Tamsulosin to Prevent Postoperative Urinary Retention: A Randomized Controlled Trial

The purpose of this study was to evaluate the efficacy of tamsulosin, administered preoperatively, for the prevention of postoperative urinary retention (POUR). POUR is a common complication of abdominal surgery, leading to the use of urinary catheters, which are a risk factor for urinary tract infe...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of surgical research 2021-06, Vol.262, p.130-139
Main Authors: Papageorge, Christina M., Howington, Bailey, Leverson, Glen, Kennedy, Gregory D., Carchman, Evie H.
Format: Article
Language:eng
Subjects:
Catheterization
Clinical trials
Health aspects
Medical research
Medicine, Experimental
Prevention
Tamsulosin
Tamsulosin hydrochloride
Urinary catheter
Urinary retention
Urinary tract infection
Urinary tract infections
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this study was to evaluate the efficacy of tamsulosin, administered preoperatively, for the prevention of postoperative urinary retention (POUR). POUR is a common complication of abdominal surgery, leading to the use of urinary catheters, which are a risk factor for urinary tract infection. Tamsulosin is a uroselective alpha-1a blocker used for the treatment of lower urinary tract symptoms. A randomized, double-blind, placebo-controlled trial was undertaken from August 2015 to May 2018. Adults undergoing elective inpatient abdominal surgery were randomized to receive either tamsulosin 0.4 mg or placebo daily for 7 d before surgery and continuing for up to 7 d postoperatively. The primary outcome was need for at least a single intermittent catheterization postoperatively. Secondary outcomes included first postvoid residual volume, number of catheterizations, need for replacement of an indwelling catheter, hospital length of stay, and urinary tract infection within 30 d of surgery. A total of 158 participants were enrolled, with a final analytic cohort of 141 participants. The two groups had similar baseline characteristics, operative characteristics, and timing of catheter removal. There was no difference in the incidence of POUR between the two groups (26% in tamsulosin versus 31% in placebo, P = 0.49). There was also no difference in any of the secondary outcomes between the two groups. Epidural usage, open surgery, and age
ISSN:0022-4804
1095-8673